期刊文献+

PPAR-γ抑制剂T0070907对人鼻咽癌细胞的生长抑制作用 被引量:6

Growth Inhibition of a Selective PPAR-γ Inhibitor,T0070907,in Nasopharyngeal Carcinoma Cells
暂未订购
导出
摘要 【目的】探讨PPAR-γ选择性抑制剂T0070907影响鼻咽癌(NPC)细胞体外生长的作用机制。【方法】通过RT-PCR和Westernblotting检测PPAR-γ受体在5株NPC细胞株(CNE1、CNE2、HONE1、SUNE1和5-8F)中mRNA和蛋白水平的表达;MTT法检测T0070907对NPC细胞生长情况的影响;流式细胞术和Westernblotting检测T0070907对NPC细胞的细胞周期和细胞周期相关蛋白表达的影响。【结果】PPAR-γ在5株NPC细胞中均有表达;T0070907对NPC细胞株有明显生长抑制作用,并呈浓度、时间依赖性;T0070907作用于NPC细胞CNE1和CNE2后,G2/M期细胞比例则逐渐增加,且随着处理浓度的增加而增加,各组间差异有统计学意义(P<0.05)。此外,随着T0070907处理浓度的增加,NPC细胞的细胞周期相关蛋白CyclinA、CyclinB1、Cdc2、Cdk2蛋白的表达逐渐下降,无活性的pCdc2蛋白表达则逐渐增强。【结论】PPAR-γ抑制剂T0070907能够抑制NPC细胞PPAR-γ的蛋白表达,并通过对细胞周期相关蛋白CyclinA、CyclinB1、Cdc2、Cdk2、pCdc2等蛋白的调控导致细胞周期G2/M期阻滞,从而抑制NPC细胞的生长。 【Objective】PPAR-γ(peroxisome proliferator-activated receptor-γ)antagonists have been documented to induce cancer cell proliferation inhibition and apoptosis.In the present study PPAR-γ's effect on cell growth of NPC cell lines and the possible mechanism was investigated via its selective inhibitor T0070907.【Methods】PPAR-γmRNA and protein expression in five human NPC cell lines(CNE1,CNE2,HONE1,SUNE1,and 5-8F)was detected with RT-PCR and Western blotting analysis.NPC cells growth inhibition by T0070907 was measured by MTT assay,and cell cycle arrest of NPC cells treated with T0070907 was assayed by fluorescence-activated cell sorter(FACS)analysis.Cell cycle-associated protein expression was detected by Western blotting.【Results】PPAR-γwas expressed both at mRNA and protein levels in five NPC cell lines.NPC cells'proliferation was significantly inhibited by T0070907,and the growth inhibition was dose-and time-dependent.CNE1 and CNE2 cells treated for 48 h with T0070907 markedly accumulated dose-dependently in the phase of G2/M,while they differed significantly(P0.05)in the phase as well.T0070907 suppressed expression of cell cycle-related proteins including Cyclin A,Cyclin B1,Cdc2,and Cdk2 but increased pCdc2 expression.【Conclusion】PPAR-γinhibitor T0070907 could induce proliferation inhibition of NPC cells to the phase of G2/M,and this cell cycle arrest might result probably from regulation of Cyclin A,Cyclin B1,Cdc2,Cdk2,and pCdc2.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2010年第3期343-349,共7页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省自然科学基金(031726)
关键词 PPAR-Γ 鼻咽癌 T0070907 细胞周期 G2/M期 PPAR-γ nasopharyngeal carcinoma T0070907 cell cycle G2/M arrest
  • 相关文献

参考文献14

  • 1Kliewer SA,Umesono K,Noonan D J,et al.Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors[J].Nature,1992,358(6389):771-774.
  • 2Michael L,Mitchell AL.The many faces of PPAR-γ[J].Cell,2005,123(6):993-999.
  • 3Grommes C,Landreth GE,Heneka MT.Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists[J].Lancet Oncol,2004,5(7):419-429.
  • 4Burton JD,Castillo ME,Goldenherg DM,et al.Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines [J].Anticancer Drugs,2007,18(5):525-534.
  • 5Takahashi H,Fujita K,Fujisawa T,et al.Inhibition of peroxisome proliferator-activated receptor gamma activity in esophageal carcinoma cells results in a drastic decrease of invasive properties[J].Cancer Sci,2006,97 (9):854-860.
  • 6Schaefer KL,Wada K,Takahashi H,et al.Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells[J].Cancer Res,2005,65 (6):2251-2259.
  • 7Schaefer KL.PPAR gamma inhibitors as novel tubulintargeting agents[J].PPAR Res,2008,2008:785405.[PubMed-in process].
  • 8Lee G,Elwood F,McNally J,et al.T0070907,a selective ligand for peroxisome proliferator-activated receptor gamma,functions as an antagonist of biochemical and cellular activities[J].J Biol Chem,2002,277(22):19649-19657.
  • 9Burton JD,Goldenberg DM,Bhmenthal RD.Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types[J].PPAR Res,2008,2008:494161.[PubMed-in process].
  • 10Zhang GY,Ahmed N,Riley C,et al.Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma[J].Br J Cancer,2005,92(1):113-119.

同被引文献58

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部